Design synthesis and antibacterial activity studies of new thiadiazoloquinolone compounds.

about

Design synthesis and antibacterial activity studies of new thiadiazoloquinolone compounds.

Item

http://www.wikidata.org/entity/Q54295509

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Design synthesis and antibacte ...... hiadiazoloquinolone compounds.

@en

Design synthesis and antibacte ...... hiadiazoloquinolone compounds.

@nl

type

Item

label

Design synthesis and antibacte ...... hiadiazoloquinolone compounds.

@en

Design synthesis and antibacte ...... hiadiazoloquinolone compounds.

@nl

prefLabel

Design synthesis and antibacte ...... hiadiazoloquinolone compounds.

@en

Design synthesis and antibacte ...... hiadiazoloquinolone compounds.

@nl

P1476

Design synthesis and antibacte ...... hiadiazoloquinolone compounds.

@en

P2093

Franca Zani

http://www.w3.org/2001/XMLSchema#string

Jalal A Zahra

http://www.w3.org/2001/XMLSchema#string

Matteo Incerti

http://www.w3.org/2001/XMLSchema#string

Mohammed M Abadleh

http://www.w3.org/2001/XMLSchema#string

Mustafa M El-Abadelah

http://www.w3.org/2001/XMLSchema#string

Paola Vicini

http://www.w3.org/2001/XMLSchema#string

Rabab Albashiti

http://www.w3.org/2001/XMLSchema#string

Raed A Al-Qawasmeh

http://www.w3.org/2001/XMLSchema#string

P2860

A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury

Clinical effectiveness of oral treatments for spasticity in multiple sclerosis: a systematic review

Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents

Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages

Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections

The 2-pyridone antibacterial agents: bacterial topoisomerase inhibitors.

Structural features of new quinolones and relationship to antibacterial activity against Gram-positive bacteria.

Topoisomerase as target for antibacterial and anticancer drug discovery.

Structure-activity relationships of the fluoroquinolones.

Modified release tizanidine: a review.

P304

777-785

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/14756366.2013.855925

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260128414

http://www.w3.org/2001/XMLSchema#string

P698

24506209

http://www.w3.org/2001/XMLSchema#string